Sort
82,697 grants matching “vaccine development”
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$2,366,186Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2010 · AI
Acute HIV Infection: Implications for vaccine design
$2,366,120Todd M Allen · Massachusetts General Hospital · P01 · FY2012 · AI
Vaccines for prescription opioid and heroin abuse
$2,365,673Paul Pentel · Hennepin Healthcare Research Institute · U01 · FY2016 · DA
Task V20: Hamster Sarbecovirus Challenge Model for SARS-CoV-2 Vaccine Testing
$2,365,162Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2024 · AI
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
$2,365,060David Montefiori · Duke University · N01 · FY2019 · AI
SPORE in Prostate Cancer
$2,365,008Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2009 · CA
SPORE in Prostate Cancer
$2,365,008Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2010 · CA
Core C: Biosecurity Core
$2,364,507James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2021 · AI
CENTER FOR RECOMBINANT GAMETE CONTRACEPTIVE VACCINOGENS
$2,363,015University Of Virginia Charlottesville · U54 · FY2001 · HD
Center for the Study of Immune Mechanisms of Flavivirus Control
$2,361,857Michael J Gale · University Of Washington · U19 · FY2015 · AI
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,361,658Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2024 · CA
Caribbean Primate Research Center Program
$2,361,241Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2022 · OD
Caribbean Primate Research Center Program
$2,361,241Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2023 · OD
HIV/SIV Data Base and Analysis Unit
$2,361,111Bette Korber · National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
Research Project 1: Discovery and dissection of virus-host interactions and pathogenetic mechanisms
$2,360,067Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2025 · AI
Mechanisms of naturally-acquired immunity to malaria
$2,359,843Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Innovative Influenza Therapeutic and Prophylactic for Biodefense Applications
$2,359,731Jane Ryan · Biota Scientific Management · U01 · FY2008 · AI
Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory
$2,359,558Anthony Griffiths · University Of Missouri-Columbia · UC7 · FY2025 · AI
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,359,432Joseph M Fox · University Of Delaware · P20 · FY2022 · GM
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,359,432Joseph M Fox · University Of Delaware · P20 · FY2021 · GM
City of Hope Lymphoma SPORE
$2,359,066Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$2,358,707Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2021 · DC
UNC Center for AIDS Research
$2,358,278Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2006 · AI
Spore in Head and Neck Cancer
$2,358,048David Sidransky · Johns Hopkins University · P50 · FY2008 · DE
Units for HIV/AIDS Clinical Trials Networks
$2,357,844Michael C Keefer · University Of Rochester · U01 · FY2010 · AI